Systemic sclerosis and the risk of cancer: A nationwide population-based cohort study

British Journal of Dermatology

Volumn 163, Issue 4, 2010, Pages 800-806

  Olesen, A B ^a   Svaerke C ^a   Farkas, D K ^a   Sorensen H T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

cancer incidence; epidemiology; population based study; risk factors; systemic sclerosis

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING HABIT; SYSTEMIC SCLEROSIS;

ADULT; AGED; ALCOHOL DRINKING; COCARCINOGENESIS; DENMARK; EPIDEMIOLOGIC METHODS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; SCLERODERMA, SYSTEMIC; SEX FACTORS; SMOKING; YOUNG ADULT;

EID: 77957040151     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09861.x     Document Type: Article

References (41)

1. Abraham DJ, Krieg T, Distler J, Distler O. Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford) 2009 48 (Suppl. 3 iii3 7.
2. Nietert PJ, Sutherland SE, Silver RM et al. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 1998 41 : 1111 1118.
3. Mora GF. Systemic sclerosis: environmental factors. J Rheumatol 2009 36 : 2383 2396.
4. Medsger TA Jr. Systemic sclerosis and malignancy - are they related? J Rheumatol 1985 12 : 1041 1043.
5. Oliver JE, Silman AJ. What epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases. Arthritis Res Ther 2009 11 : 223.
6. Rosenthal AK, McLaughlin JK, Gridley G et al. Incidence of cancer among patients with systemic sclerosis. Cancer 1995 76 : 910 914.
7. Hill CL, Nguyen AM, Roder D et al. Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 2003 62 : 728 731.
8. Abu-Shakra M, Guillemin F, Lee P. Cancer in systemic sclerosis. Arthritis Rheum 1993 36 : 460 464.
9. Roumm AD, Medsger TA Jr. Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum 1985 28 : 1336 1340.
10. Rosenthal AK, McLaughlin JK, Linet MS et al. Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis 1993 52 : 531 533.
11. Launay D, Le Berre R, Hatron PY et al. Association between systemic sclerosis and breast cancer: eight new cases and review of the literature. Clin Rheumatol 2004 23 : 516 522.
12. Lee P, Alderdice C, Wilkinson S et al. Malignancy in progressive systemic sclerosis - association with breast carcinoma. J Rheumatol 1983 10 : 665 666.
13. Scope A, Sadetzki S, Sidi Y et al. Breast cancer and scleroderma. Skinmed 2006 5 : 18 24.
14. Derk CT. Associations of breast cancer development in patients with systemic sclerosis: an exploratory study. Clin Rheumatol 2007 26 : 1615 1619.
15. Sakkas LI, Moore DF, Akritidis NC. Cancer in families with systemic sclerosis. Am J Med Sci 1995 310 : 223 225.
16. Diot E, Lesire V, Guilmot JL et al. Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med 2002 59 : 545 549.
17. Schottenfeld D, Beebe-Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 2006 56 : 69 83.
18. Daniels CE, Jett JR. Does interstitial lung disease predispose to lung cancer? Curr Opin Pulm Med 2005 11 : 431 437.
19. Roberts-Thomson PJ, Male DA, Walker JG et al. Genomic instability in scleroderma. Asian Pac J Allergy Immunol 2004 22 : 153 158.
20. Leone G, Mele L, Pulsoni A et al. The incidence of secondary leukemias. Haematologica 1999 84 : 937 945.
21. Leone G, Pagano L, Ben-Yehuda D et al. Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica 2007 92 : 1389 1398.
22. Andersen TF, Madsen M, Jorgensen J et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999 46 : 263 268.
23. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980 23 : 581 590.
24. Storm HH, Michelsen EV, Clemmensen IH et al. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull 1997 44 : 535 539.
25. Sundhedsstyrelsen. Cancerregisteret 2007. Available at: http://www.sst.dk/publ/Publ2009/DOKU/cancerreg/cancerregister2007.pdf (last accessed 26 May 2010).
26. Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol 2006 7 : 149 156.
27. Boyle P. Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996. Lung Cancer 1997 17 : 1 60.
28. Friis S, Sørensen HT, Mellemkjaer L et al. Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark. Cancer 2001 92 : 2462 2470.
29. Peters-Golden M, Wise RA, Hochberg M et al. Incidence of lung cancer in systemic sclerosis. J Rheumatol 1985 12 : 1136 1139.
30. Talbott JH, Barrocas M. Carcinoma of the lung in progressive systemic sclerosis: a tabular review of the literature and a detailed report of the roentgenographic changes in two cases. Semin Arthritis Rheum 1980 9 : 191 217.
31. Kanaji N, Fujita J, Bandoh S et al. Small cell lung cancer associated with systemic sclerosis. Intern Med 2005 44 : 315 318.
32. Winkelmann RK, Flach DB, Unni KK. Lung cancer and scleroderma. Arch Dermatol Res 1988 280 (Suppl. S15 18.
33. Kuwana M, Fujii T, Mimori T, Kaburaki J. Enhancement of anti-DNA topoisomerase I autoantibody response after lung cancer in patients with systemic sclerosis. A report of two cases. Arthritis Rheum 1996 39 : 686 691.
34. Rothfield N, Kurtzman S, Vazques-Abad D et al. Association of anti-topoisomerase I with cancer. Arthritis Rheum 1992 35 : 724.
35. Pontifex EK, Hill CL, Roberts-Thomson P. Risk factors for lung cancer in patients with scleroderma: a nested case-control study. Ann Rheum Dis 2007 66 : 551 553.
36. Duncan SC, Winkelmann RK. Cancer and scleroderma. Arch Dermatol 1979 115 : 950 955.
37. Doyle JA, Connolly SM, Hoagland HC. Hematologic disease in scleroderma syndromes. Acta Derm Venereol (Stockh) 1985 65 : 521 525.
38. Bielefeld P, Meyer P, Caillot D et al. [Systemic scleroderma and cancers: 21 cases and review of the literature]. Rev Med Interne 1996 17 : 810 813.
39. Kishi S, Yang W, Boureau B et al. Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia. Blood 2004 103 : 67 72.
40. Pan SF, Rodnan GP, Deutsch M et al. Chromosomal abnormalities in progressive systemic sclerosis (scleroderma) with consideration of radiation effects. J Lab Clin Med 1975 86 : 300 308.
41. Marasini B, Conciato L, Belloli L et al. Systemic sclerosis and cancer. Int J Immunopathol Pharmacol 2009 22 : 573 578.